Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GHRS
#2436
GH Research PLC Ordinary Shares
16.770
0
USD
+2.63%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.63%
Monthly Change
+11.43%
6 month change
+18.43%
Year Change
+18.43%
Previous Close
16.340
0
Open
16.770
0
Bid
Ask
Low
16.770
0
High
16.770
0
Volume
15
Markets
US Stock Market
Healthcare
GHRS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
52.02 M
52.02 M
52.03 M
52.03 M
62.03 M
218.11 M
Valuation ratios
Enterprise value
936.87 M
337.09 M
199.93 M
263.41 M
541.52 M
1.93 B
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.09
0.16
0.21
0.17
—
Return on equity %
0.03
0.09
0.16
0.22
0.17
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
101.8
37.07
24.49
17.23
34.13
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
News
Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3
Guggenheim raises GH Research stock price target to $34 on trial data
Needham raises GH Research stock price target to $32 on phase 3 plans
Citizens raises GH Research stock price target on phase 3 progress
GH Research reports Phase 2b trial results for depression treatment
GH Research stock price target raised to $40 from $33 at RBC Capital
Eli Lilly and Regencell among market cap stock movers on Wednesday
GH Research stock price target raised to $29 from $19 at Needham
GH Research stock jumps as Canaccord raises price target on FDA hold lift
GH Research stock rises as FDA lifts clinical hold on GH001
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug